Volume 4, Issue 1
Transarterial Chemoembolization with Doxorubicin-Eluting Microspheres for Inoperable Hepatocellular Carcinomas
Sanjeeva P. Kalva, Shams I. Iqbal, Kalpana Yeddula, Lawrence S. Blaszkowsky, Adnan Akbar, Stephan Wicky, Andrew X. Zhu
Pages 2–8
Phase II Trial of Docetaxel and Carboplatin in Patients with Advanced Squamous Carcinoma of the Esophagus (E2298): A Trial of the Eastern Cooperative Oncology Group
Joanne F. Rossman, Carla I. Falkson, Ronghui Xu, Coenraad F. Slabber, Bernard A. Mason, Mary F. Mulcahy, Al B. Benson III
Pages 9–14
Molecularly Targeted Therapy for Metastatic Colon Cancer: Proven Treatments and Promising New Agents
Majed El Zouhairi, Aline Charabaty, Michael J. Pishvaian
Pages 15–21
Volume 4, Issue 2
Safety and Efficacy of Sorafenib in Patients with Hepatocellular Carcinoma (HCC) and Child-Pugh A versus B Cirrhosis
Ghassan K. Abou-Alfa, Dino Amadori, Armando Santoro, Arie Figer, Jacques De Greve, Chetan Lathia, Dimitris Voliotis, Sibyl Anderson, Marius Moscovici, Sergio Ricci
Pages 40–44
Longitudinal Quality-of-Life Analysis of RTOG 94-05 (Int 0123): A Phase III Trial of Definitive Chemoradiotherapy for Esophageal Cancer
Lisa A. Kachnic, Kathryn Winter, Todd Wasserman, David Kelsen, Robert Ginsberg, Thomas M. Pisansky, James Martenson, Ritsuko Komaki, Gordon Okawara, Seth A. Rosenthal, Christopher G. Willett, Bruce D. Minsky
Pages 45–52
Current Management of Inflammatory Bowel Disease and Colorectal Cancer
Mark C. Mattar, Denver Lough, Michael J. Pishvaian, Aline Charabaty
Pages 53–61
HER2 Testing in Gastric/Gastroesophageal Junction Adenocarcinomas: Unique Features of a Familiar Test
Jeffrey S. Ross, Mary Mulcahy
Pages 62–66
Volume 4, Issue 3
Phase II Study of Capecitabine, Oxaliplatin, and Cetuximab for Advanced Hepatocellular Carcinoma
Hanna K. Sanoff, Stephen Bernard, Richard M. Goldberg, Michael A. Morse, Reynaldo Garcia, Lynna Woods, Dominic T. Moore, Bert H. O'Neil
Pages 78–83
Decreased Posttreatment SUV on PET Scan Is Associated With Improved Local Control in Medically Inoperable Esophageal Cancer
Navesh K. Sharma, Joshua S. Silverman, Tianyu Li, Jonathan Cheng, Jian Q. Yu, Oleh Haluszka, Walter Scott, Neal J. Meropol, Steven J. Cohen, Gary M. Freedman, Andre A. Konski
Pages 84–89
Low-Lying Rectal Cancer With Anal Canal Involvement: Abdominoperineal or Low Anterior Resection After Neoadjuvant Chemoradiotherapy
Ly Do, Nisar Syed, Ajmel Puthawala, Samar Azawi, Imad Shbeeb, I-yeh Gong
Pages 90–95
Refining Docetaxel-Containing Therapy for Gastric Cancer
Nushmia Z. Khokhar, Yixing Jiang, Al B. Benson, III, Jaffer A. Ajani, Mary F. Mulcahy
Pages 96–105
Volume 4, Issue 4
Intraductal Papillary Mucinous Adenocarcinoma of the Pancreas: Clinical Outcomes, Prognostic Factors, and the Role of Adjuvant Therapy
Brian M. Alexander, Carlos Fernandez-del Castillo, David P. Ryan, Lisa A. Kachnic, Aram F. Hezel, Andrzej Niemierko, Christopher G. Willett, Kevin R. Kozak, Lawrence S. Blaszkowsky, Jeffrey W. Clark, Andrew L. Warshaw, Theodore S. Hong
Pages 116–121
Advanced Gastric Cancer in Jordan From 2004 to 2008: A Study of Epidemiology and Outcomes
Salah Y. Abbasi, Hani El Taani, Adnan Saad, Ahmed Badheeb, Ala' Addasi
Pages 122–127
Comparison of 1-, 2-, and 3-Dimensional Tumor Response Assessment After Neoadjuvant GTX-RT in Borderline-Resectable Pancreatic Cancer
Michael D. Chuong, Tom J. Hayman, Manish R. Patel, Mark S. Russell, Mokenge P. Malafa, Pamela J. Hodul, Gregory M. Springett, Junsung Choi, Ravi Shridhar, Sarah E. Hoffe
Pages 128–134
Volume 4, Issue 5–6
Chemotherapy Outcomes for the Treatment of Unresectable Intrahepatic and Hilar Cholangiocarcinoma: A Retrospective Analysis
Karen R. Eckmann, Dina K. Patel, Andrea Landgraf, Julian H. Slade, E. Lin, Harmeet Kaur, Evelyne Loyer, Jacqueline M. Weatherly, Milind Javle
Pages 155–160
Association Between Dietary Fiber and Incident Cases of Colon Polyps: The Adventist Health Study
Yessenia M. Tantamango, Synnove F. Knutsen, Larry Beeson, Gary Fraser, Joan Sabate
Pages 161–167
Prognostic Factors for Metastatic Colorectal Cancer Patients Undergoing Irinotecan-Based Second-Line Chemotherapy
Kohei Shitara, Keitaro Matsuo, Tomoya Yokota, Daisuke Takahari, Takashi Shibata, Takashi Ura, Yoshitaka Inaba, Hidekazu Yamaura, Yozo Sato, Mina Najima, Kei Muro
Pages 168–172
Factors Influencing Progression-Free Survival in Gastrointestinal Stromal Tumors With Special Reference to Pathologic Features, Cytogenetics, and Radiologic Response
Suresh V. Attili, BB Ananda, T. Mandapal, V. Anjaneyulu, Sudha Sinha, Obula C. Reddy
Pages 173–177